Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q1 2023 · 10-Q
Revenue$15.52M$15.52M+98.7% vs Q1 2022 Net Income-$1.18M-$1.18MN/M vs Q1 2022 EPS Diluted-$0.14-$0.14no prior Q1 2022 on file Gross Profit$13,396,258+91.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flow-$1,741,313N/M Free Cash Flowderived-$1,769,018N/M Margins · derivedGross margin86.3%−3.4 pt vs Q1 2022
Operating margin-7.8%+27.7 pt vs Q1 2022
Net margin-7.6%+32.5 pt vs Q1 2022
ended Mar 31, 2023 · filed May 15, 2023 · 45 d after period end